ResearcherUniversity of Southern CaliforniaActive in the last 2 years
Hyungsik Roger Moon
Matched on ORCID iD 0000-0002-5626-1600; OpenAlex author ID A5053993503. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2023: 1 paper · 2024: 2 papers
Papers 3
- Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin leve… Co-author DOI 10.1038/s41416-023-02474-w↗
- Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum … Co-author DOI 10.1038/s41416-023-02520-7↗
- Copula graphic estimation of the survival function with dependent censoring and its application to analysis of pancreatic cancer clinical trial. Last author DOI 10.1177/09622802231158812↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Si Young Song · 3 shared papers, 2023–2024 · strength 0.55
- Paper Copula graphic estimation of the survival function with dependent censoring and its application to analysis of pancreat… DOI 10.1177/09622802231158812↗
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Jung Hyun Jo · 3 shared papers, 2023–2024 · strength 0.55
- Paper Copula graphic estimation of the survival function with dependent censoring and its application to analysis of pancreat… DOI 10.1177/09622802231158812↗
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Chang‐Hwan Park · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Jae Woo Kim · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Eui Joo Kim · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Mi‐Suk Park · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Hong Sik Lee · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Y. Choi · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Eun Kwang Choi · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Dong Uk Kim · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Seung Ok Lee · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Young Woo Choi · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Ho Gak Kim · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Ho Soon Choi · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Woo Jin Lee · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Yong‐Tae Kim · 2 shared papers, 2024 · strength 0.33
- Paper Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno… DOI 10.1038/s41416-023-02474-w↗
- Paper Correction: Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic … DOI 10.1038/s41416-023-02520-7↗
- Kwang Hyuck Lee · 1 shared paper, 2024 · strength 0.16
- Kwang Hyuck Lee · 1 shared paper, 2024 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.